tiprankstipranks
TNF Pharmaceuticals (TNFA)
NASDAQ:TNFA
US Market

TNF Pharmaceuticals (TNFA) Income Statement

Compare
551 Followers

TNF Pharmaceuticals Income Statement

Last quarter (Q3 2024), TNF Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, TNF Pharmaceuticals's net income was $-1.93M. See TNF Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -29.45K$ -74.06K
Operating Expenses
$ 17.12M$ 15.28M$ 28.20M$ 12.26M$ 3.32M
Depreciation and Amortization
$ 13.12M$ 15.28M$ 18.33K$ 29.45K$ 74.06K
EBITDA
$ -4.00M$ 0.00$ -29.28M$ -12.12M$ -3.31M
Operating Income
$ -17.12M$ -15.28M$ -28.20M$ -12.29M$ -3.40M
Other Income/Expenses
$ 13.12M$ 85.43K$ -1.08M$ 141.00$ 15.81K
Pretax Income
$ -4.00M$ -15.20M$ -29.89M$ -12.15M$ -3.38M
Net Income
$ -4.00M$ -15.20M$ -29.89M$ -17.58M$ -3.89M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.33$ -11.74$ -25.61$ -149.57$ -380.79
Diluted EPS
$ -5.33$ -11.74$ -25.61$ -149.57$ -380.79
Weighted Average Shares Outstanding
1.54M 1.29M 1.17M 117.54K 10.21K
Weighted Average Shares Outstanding (Diluted)
1.54M 1.29M 1.17M 117.54K 10.21K
Currency in USD

TNF Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis